Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$6.37 - $15.23 $913,209 - $2.18 Million
-143,361 Reduced 75.84%
45,665 $691,000
Q2 2022

Aug 15, 2022

BUY
$4.95 - $9.16 $24,809 - $45,909
5,012 Added 2.72%
189,026 $1.42 Million
Q1 2022

May 13, 2022

BUY
$5.64 - $9.8 $304,018 - $528,259
53,904 Added 41.43%
184,014 $1.68 Million
Q4 2021

Feb 14, 2022

BUY
$7.02 - $13.33 $196,447 - $373,026
27,984 Added 27.4%
130,110 $913,000
Q3 2021

Nov 15, 2021

BUY
$11.32 - $16.63 $233,044 - $342,361
20,587 Added 25.25%
102,126 $1.16 Million
Q2 2021

Aug 13, 2021

SELL
$15.16 - $18.97 $58,214 - $72,844
-3,840 Reduced 4.5%
81,539 $1.31 Million
Q1 2021

May 14, 2021

SELL
$13.12 - $20.9 $132,708 - $211,403
-10,115 Reduced 10.59%
85,379 $1.53 Million
Q4 2020

Feb 12, 2021

SELL
$9.12 - $14.49 $567,592 - $901,799
-62,236 Reduced 39.46%
95,494 $1.29 Million
Q3 2020

Nov 16, 2020

BUY
$10.46 - $14.46 $611,146 - $844,854
58,427 Added 58.84%
157,730 $1.86 Million
Q2 2020

Aug 14, 2020

BUY
$12.0 - $16.13 $160,992 - $216,400
13,416 Added 15.62%
99,303 $1.47 Million
Q1 2020

May 14, 2020

SELL
$11.84 - $25.52 $501,648 - $1.08 Million
-42,369 Reduced 33.03%
85,887 $1.16 Million
Q4 2019

Feb 13, 2020

SELL
$17.72 - $25.1 $389,609 - $551,873
-21,987 Reduced 14.63%
128,256 $3.08 Million
Q3 2019

Nov 19, 2019

BUY
$18.41 - $28.0 $10,291 - $15,652
559 Added 0.37%
150,243 $2.89 Million
Q3 2019

Nov 13, 2019

BUY
$18.41 - $28.0 $859,857 - $1.31 Million
46,706 Added 45.36%
149,684 $2.88 Million
Q2 2019

Aug 14, 2019

BUY
$28.97 - $48.21 $217,912 - $362,635
7,522 Added 7.88%
102,978 $3.04 Million
Q1 2019

May 14, 2019

BUY
$36.32 - $49.25 $313,078 - $424,535
8,620 Added 9.93%
95,456 $4.55 Million
Q4 2018

Feb 13, 2019

BUY
$33.0 - $60.04 $97,548 - $177,478
2,956 Added 3.52%
86,836 $3.15 Million
Q3 2018

Nov 13, 2018

BUY
$56.15 - $73.9 $315,282 - $414,948
5,615 Added 7.17%
83,880 $5.15 Million
Q2 2018

Aug 14, 2018

BUY
$47.85 - $70.45 $52,108 - $76,720
1,089 Added 1.41%
78,265 $5.29 Million
Q1 2018

May 11, 2018

SELL
$51.15 - $61.0 $423,624 - $505,202
-8,282 Reduced 9.69%
77,176 $4.18 Million
Q4 2017

Feb 14, 2018

BUY
$50.85 - $65.1 $31,577 - $40,427
621 Added 0.73%
85,458 $5.1 Million
Q3 2017

Nov 13, 2017

BUY
$48.6 - $60.1 $4.12 Million - $5.1 Million
84,837
84,837 $0

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.